/  January 16, 2017

UW CoMotion spinoff Phase Genomics launches platform for genome assembly

Over the last three years, CoMotion at the University of Washington has partnered with Phase Genomics to provide dramatically improved genome and metagenome assemblies. These efforts included a grant awarded from the CoMotion Innovation Fund,  Commercialization Fellowships provided to an inventor and founder early in the project, execution of confidentiality agreements to protect the underlying UW-owned intellectual property, and the negotiation of an option, as well as the recently signed exclusive licensing agreement.

Phase Genomics, Inc., launched through CoMotion at UW, has announced the general availability of ProximoTM, a new service providing complete end-to-end genome assemblies to researchers around the globe.

Click on the link to learn more about the news.